Thirteen years experience with selective screening for disorders in purine and pyrimidine metabolism.

Abstract

Purine and pyrimidine disorders represent a heterogeneous group with variable clinical symptoms and low prevalence rate. In the last thirteen years, we have studied urine/plasma specimens from about 1600 patients and we have identified 35 patients: eight patients with adenylosuccinate lyase deficiency, eight patients with hypoxanthine-guanine phosphoribosyltransferase deficiency, one patient with purine nucleoside phosphorylase deficiency, ten patients with xanthine dehydrogenase deficiency, six patients with molybdenum cofactor deficiency and two patients with dihydropyrimidine dehydrogenase deficiency. Despite low incidence of these diseases, our findings highlight the importance of including the purine and pyrimidine analysis in the selective screening for inborn errors of metabolism in specialized laboratories, where amino acid and organic acid disorders are simultaneously investigated.

• Authors: M Castro, R Carrillo, F García, P Sanz, I Ferrer, P Ruiz-Sala, A I Vega, L Ruíz Desviat, B Pérez, C Pérez-Cerdá, B Merinero, M Ugarte
• Journal: Nucleosides, nucleotides & nucleic acids (Nucleosides Nucleotides Nucleic Acids) Vol. 33 Issue 4-6 Pg. 233-40 ( 2014) ISSN: 1532-2335 [Electronic] United States
• PMID: 24940674 (Publication Type: Journal Article, Review)

Topics

• Humans
• Purine-Pyrimidine Metabolism, Inborn Errors (diagnosis, enzymology)